The association of BRAFV600E mutation with molecular features.

How the BRAF V600E mutation defines a distinct subgroup of colorectal cancer: molecular and clinical implications

Bond, Catherine E.
Whitehall, Vicki L. J.

January 2018

The BRAF oncogene is an integral component of the MAP kinase pathway, and an activating V600E mutati...

The yin-yang of kinase activation and unfolding explains the peculiarity of Val600 in the activation segment of BRAF

Kiel, Christina
Benisty, Hannah, 1986-
Lloréns Rico, Verónica, 1989-
Serrano Pubull, Luis, 1982-

January 2016

Many driver mutations in cancer are specific in that they occur at significantly higher rates than -...

Random effect model of Log hazard ratio (LogHR) with 95% confidence interval for studies comparing the effect of BRAF-V600E mutation on overall survival of colorectal cancer patients.

Gholamreza Safaee Ardekani (128339)
Seyed Mehdi Jafarnejad (128343)
Larry Tan (128346)
Ardavan Saeedi (128349)
Gang Li (34549)

October 2012

A LogHR <0 implies a survival benefit for patients with BRAF mutation. The square size ind...

The association of BRAFV600E mutation with demographics.

Dong Chen (448284)
Jun-Fu Huang (529829)
Kai Liu (159026)
Li-Qun Zhang (409394)
Zhao Yang (358244)
Zheng-Ran Chuai (529830)
Yun-Xia Wang (529831)
Da-Chuan Shi (529832)
Qing Huang (240196)
Wei-Ling Fu (529833)

March 2014

Random effects model of the odds ratios (ORs) with 95% confidence intervals (CIs) for the associa...

The association of BRAFV600E mutation with life style.

Dong Chen (448284)
Jun-Fu Huang (529829)
Kai Liu (159026)
Li-Qun Zhang (409394)
Zhao Yang (358244)
Zheng-Ran Chuai (529830)
Yun-Xia Wang (529831)
Da-Chuan Shi (529832)
Qing Huang (240196)
Wei-Ling Fu (529833)

March 2014

Fixed effects model of the odds ratios (ORs) with 95% confidence intervals (CIs) of the associati...

The association of BRAFV600E mutations with gender (A), smoking (B) and stage (C).

Dong Chen (448284)
Li-Qun Zhang (409394)
Jun-Fu Huang (529829)
Kai Liu (159026)
Zheng-Ran Chuai (529830)
Zhao Yang (358244)
Yun-Xia Wang (529831)
Da-Chuan Shi (529832)
Qian Liu (135614)
Qing Huang (240196)
Wei-Ling Fu (529833)

June 2014

The association of BRAFV600E mutations with gender (A), smoking (B) and stage (C).</p

The association between BRAF mutation and TNM classification and other pathological factors.

Agnieszka Czarniecka (770267)
Monika Kowal (770268)
Dagmara Rusinek (770269)
Jolanta Krajewska (770270)
Michal Jarzab (313704)
Ewa Stobiecka (770271)
Ewa Chmielik (770272)
Ewa Zembala-Nozynska (770273)
Stanislaw Poltorak (770274)
Aleksander Sacher (770275)
Adam Maciejewski (770276)
Jadwiga Zebracka-Gala (770277)
Dariusz Lange (330266)
Malgorzata Oczko-Wojciechowska (770278)
Daria Handkiewicz-Junak (770279)
Barbara Jarzab (2550385)

July 2015

The association between BRAF mutation and TNM classification and other pathological factor...

Multivariate logistic regression model associations between patient, tumor and KRAS or BRAFV600E mutation status.

Wenbin Li (92586)
Wenxue Zhi (749577)
Shuangmei Zou (749578)
Tian Qiu (156003)
Yun Ling (178318)
Ling Shan (155985)
Susheng Shi (749579)
Jianming Ying (155982)

June 2015

CI = confidence interval; pMMR = proficient mismatch repair; OR = odds ratio.Multivariate ...

The association of BRAF mutations with gender (A), smoking (B), histology (C) and stage (D).

Dong Chen (448284)
Li-Qun Zhang (409394)
Jun-Fu Huang (529829)
Kai Liu (159026)
Zheng-Ran Chuai (529830)
Zhao Yang (358244)
Yun-Xia Wang (529831)
Da-Chuan Shi (529832)
Qian Liu (135614)
Qing Huang (240196)
Wei-Ling Fu (529833)

June 2014

The association of BRAF mutations with gender (A), smoking (B), histology (C) and stage (D).</p

Odds ratios for CRC risk by KRAS and BRAF mutation status per allele of the CTH rs1021737 SNP.

Robin Myte (5143100)
Björn Gylling (5143103)
Jenny Häggström (418281)
Jörn Schneede (5143094)
Anna Löfgren-Burström (5143097)
Jeroen R. Huyghe (686616)
Göran Hallmans (147486)
Klaus Meyer (442224)
Ingegerd Johansson (7760)
Per Magne Ueland (146309)
Richard Palmqvist (156586)
Bethany Van Guelpen (3905227)

April 2018

Odds ratios for CRC risk by KRAS and BRAF mutation status per allele of the CTH<...

Random effect model of Log hazard ratio (LogHR) with 95% confidence interval for studies comparing the effect of BRAF-V600E mutation on overall survival in melanoma patients.

Gholamreza Safaee Ardekani (128339)
Seyed Mehdi Jafarnejad (128343)
Larry Tan (128346)
Ardavan Saeedi (128349)
Gang Li (34549)

October 2012

A LogHR <0 implies a survival benefit for patients with BRAF mutation. The square size ind...

The frequency of KRAS, BRAF and PIK3CA mutations according to different patterns.

Chen Mao (166261)
Junhua Zhou (166263)
Zuyao Yang (166267)
Yafang Huang (166269)
Xinyin Wu (166273)
Hong Shen (166278)
Jinling Tang (166283)
Qing Chen (131379)

May 2012

The frequency of KRAS, BRAF and PIK3CA mutations according to different patterns.</p

Association of the BRAFV600E mutation with clinicopathologic characteristics of patients with PTC.

Ah Young Park (244112)
Eun Ju Son (622829)
Jeong-Ah Kim (81814)
Ji Hyun Youk (294160)
Yun Joo Park (648268)
Cheong Soo Park (648269)
Hang Seok Chang (648270)

October 2014

Data are raw numbers, percentages are in parentheses.Abbreviations: PTMC, papillary thyroi...

Association of KRAS, BRAF and PIK3CA mutations and loss of PTEN expression with clinical and pathologic characteristics.

Chen Mao (166261)
Junhua Zhou (166263)
Zuyao Yang (166267)
Yafang Huang (166269)
Xinyin Wu (166273)
Hong Shen (166278)
Jinling Tang (166283)
Qing Chen (131379)

May 2012

Association of KRAS, BRAF and PIK3CA mutations and loss of PTEN expression with clinical and path...

How the BRAF V600E Mutation Defines a Distinct Subgroup of Colorectal Cancer: Molecular and Clinical Implications

Catherine E. Bond
Vicki L. J. Whitehall

January 2018

The BRAF oncogene is an integral component of the MAP kinase pathway, and an activating V600E mutati...

How the BRAF V600E mutation defines a distinct subgroup of colorectal cancer: molecular and clinical implications

Bond, Catherine E.
Whitehall, Vicki L. J.

January 2018

The BRAF oncogene is an integral component of the MAP kinase pathway, and an activating V600E mutati...

The yin-yang of kinase activation and unfolding explains the peculiarity of Val600 in the activation segment of BRAF

Kiel, Christina
Benisty, Hannah, 1986-
Lloréns Rico, Verónica, 1989-
Serrano Pubull, Luis, 1982-

January 2016

Many driver mutations in cancer are specific in that they occur at significantly higher rates than -...

Random effect model of Log hazard ratio (LogHR) with 95% confidence interval for studies comparing the effect of BRAF-V600E mutation on overall survival of colorectal cancer patients.

Gholamreza Safaee Ardekani (128339)
Seyed Mehdi Jafarnejad (128343)
Larry Tan (128346)
Ardavan Saeedi (128349)
Gang Li (34549)

October 2012

A LogHR <0 implies a survival benefit for patients with BRAF mutation. The square size ind...

The association of BRAFV600E mutation with demographics.

Dong Chen (448284)
Jun-Fu Huang (529829)
Kai Liu (159026)
Li-Qun Zhang (409394)
Zhao Yang (358244)
Zheng-Ran Chuai (529830)
Yun-Xia Wang (529831)
Da-Chuan Shi (529832)
Qing Huang (240196)
Wei-Ling Fu (529833)

March 2014

Random effects model of the odds ratios (ORs) with 95% confidence intervals (CIs) for the associa...

The association of BRAFV600E mutation with life style.

Dong Chen (448284)
Jun-Fu Huang (529829)
Kai Liu (159026)
Li-Qun Zhang (409394)
Zhao Yang (358244)
Zheng-Ran Chuai (529830)
Yun-Xia Wang (529831)
Da-Chuan Shi (529832)
Qing Huang (240196)
Wei-Ling Fu (529833)

March 2014

Fixed effects model of the odds ratios (ORs) with 95% confidence intervals (CIs) of the associati...

The association of BRAFV600E mutations with gender (A), smoking (B) and stage (C).

Dong Chen (448284)
Li-Qun Zhang (409394)
Jun-Fu Huang (529829)
Kai Liu (159026)
Zheng-Ran Chuai (529830)
Zhao Yang (358244)
Yun-Xia Wang (529831)
Da-Chuan Shi (529832)
Qian Liu (135614)
Qing Huang (240196)
Wei-Ling Fu (529833)

June 2014

The association of BRAFV600E mutations with gender (A), smoking (B) and stage (C).</p

The association between BRAF mutation and TNM classification and other pathological factors.

Agnieszka Czarniecka (770267)
Monika Kowal (770268)
Dagmara Rusinek (770269)
Jolanta Krajewska (770270)
Michal Jarzab (313704)
Ewa Stobiecka (770271)
Ewa Chmielik (770272)
Ewa Zembala-Nozynska (770273)
Stanislaw Poltorak (770274)
Aleksander Sacher (770275)
Adam Maciejewski (770276)
Jadwiga Zebracka-Gala (770277)
Dariusz Lange (330266)
Malgorzata Oczko-Wojciechowska (770278)
Daria Handkiewicz-Junak (770279)
Barbara Jarzab (2550385)

July 2015

The association between BRAF mutation and TNM classification and other pathological factor...

Multivariate logistic regression model associations between patient, tumor and KRAS or BRAFV600E mutation status.

Wenbin Li (92586)
Wenxue Zhi (749577)
Shuangmei Zou (749578)
Tian Qiu (156003)
Yun Ling (178318)
Ling Shan (155985)
Susheng Shi (749579)
Jianming Ying (155982)

June 2015

CI = confidence interval; pMMR = proficient mismatch repair; OR = odds ratio.Multivariate ...

The association of BRAF mutations with gender (A), smoking (B), histology (C) and stage (D).

Dong Chen (448284)
Li-Qun Zhang (409394)
Jun-Fu Huang (529829)
Kai Liu (159026)
Zheng-Ran Chuai (529830)
Zhao Yang (358244)
Yun-Xia Wang (529831)
Da-Chuan Shi (529832)
Qian Liu (135614)
Qing Huang (240196)
Wei-Ling Fu (529833)

June 2014

The association of BRAF mutations with gender (A), smoking (B), histology (C) and stage (D).</p

Odds ratios for CRC risk by KRAS and BRAF mutation status per allele of the CTH rs1021737 SNP.

Robin Myte (5143100)
Björn Gylling (5143103)
Jenny Häggström (418281)
Jörn Schneede (5143094)
Anna Löfgren-Burström (5143097)
Jeroen R. Huyghe (686616)
Göran Hallmans (147486)
Klaus Meyer (442224)
Ingegerd Johansson (7760)
Per Magne Ueland (146309)
Richard Palmqvist (156586)
Bethany Van Guelpen (3905227)

April 2018

Odds ratios for CRC risk by KRAS and BRAF mutation status per allele of the CTH<...

Random effect model of Log hazard ratio (LogHR) with 95% confidence interval for studies comparing the effect of BRAF-V600E mutation on overall survival in melanoma patients.

Gholamreza Safaee Ardekani (128339)
Seyed Mehdi Jafarnejad (128343)
Larry Tan (128346)
Ardavan Saeedi (128349)
Gang Li (34549)

October 2012

A LogHR <0 implies a survival benefit for patients with BRAF mutation. The square size ind...

The frequency of KRAS, BRAF and PIK3CA mutations according to different patterns.

Chen Mao (166261)
Junhua Zhou (166263)
Zuyao Yang (166267)
Yafang Huang (166269)
Xinyin Wu (166273)
Hong Shen (166278)
Jinling Tang (166283)
Qing Chen (131379)

May 2012

The frequency of KRAS, BRAF and PIK3CA mutations according to different patterns.</p

Association of the BRAFV600E mutation with clinicopathologic characteristics of patients with PTC.

Ah Young Park (244112)
Eun Ju Son (622829)
Jeong-Ah Kim (81814)
Ji Hyun Youk (294160)
Yun Joo Park (648268)
Cheong Soo Park (648269)
Hang Seok Chang (648270)

October 2014

Data are raw numbers, percentages are in parentheses.Abbreviations: PTMC, papillary thyroi...

Association of KRAS, BRAF and PIK3CA mutations and loss of PTEN expression with clinical and pathologic characteristics.

Chen Mao (166261)
Junhua Zhou (166263)
Zuyao Yang (166267)
Yafang Huang (166269)
Xinyin Wu (166273)
Hong Shen (166278)
Jinling Tang (166283)
Qing Chen (131379)

May 2012

Association of KRAS, BRAF and PIK3CA mutations and loss of PTEN expression with clinical and path...

How the BRAF V600E Mutation Defines a Distinct Subgroup of Colorectal Cancer: Molecular and Clinical Implications

Catherine E. Bond
Vicki L. J. Whitehall

January 2018

The BRAF oncogene is an integral component of the MAP kinase pathway, and an activating V600E mutati...

How the BRAF V600E mutation defines a distinct subgroup of colorectal cancer: molecular and clinical implications

Bond, Catherine E.
Whitehall, Vicki L. J.

January 2018

The BRAF oncogene is an integral component of the MAP kinase pathway, and an activating V600E mutati...

The yin-yang of kinase activation and unfolding explains the peculiarity of Val600 in the activation segment of BRAF

Kiel, Christina
Benisty, Hannah, 1986-
Lloréns Rico, Verónica, 1989-
Serrano Pubull, Luis, 1982-

January 2016

Many driver mutations in cancer are specific in that they occur at significantly higher rates than -...

Random effect model of Log hazard ratio (LogHR) with 95% confidence interval for studies comparing the effect of BRAF-V600E mutation on overall survival of colorectal cancer patients.

Gholamreza Safaee Ardekani (128339)
Seyed Mehdi Jafarnejad (128343)
Larry Tan (128346)
Ardavan Saeedi (128349)
Gang Li (34549)

October 2012

A LogHR <0 implies a survival benefit for patients with BRAF mutation. The square size ind...

The association of BRAF<sup>V600E</sup> mutation with molecular features.

Abstract

Extracted data

The association of BRAF<sup>V600E</sup> mutation with molecular features.

Abstract

Extracted data

Related items

Related items